Skip to main content
Intended for healthcare professionals
Restricted access
Research article
First published online November 4, 2018

Complete ciprofloxacin resistance in gonococcal isolates in an urban Ugandan clinic: findings from a cross-sectional study

Abstract

Antimicrobial resistance (AMR) to gonorrhoea is a threat to global health security. There have been concerns expressed that countries with high rates of disease have poor surveillance. The objectives of the study were to determine the AMR patterns of Neisseria gonorrhoeae clinical isolates to antimicrobial agents in patients with HIV or high risk of HIV acquisition, to compare the concordance of disk diffusion and agar dilution as methods for determining AMR to N. gonorrhoeae, and to describe methodological challenges to carrying out AMR testing. The study was conducted at an HIV outpatient service for at-risk populations and an outreach clinic for commercial sex workers in Kampala. Patients were offered a sexually transmitted infection screen using a polymerase chain reaction (PCR)-based assay. Samples positive for gonorrhoea were cultured. Antimicrobial susceptibility testing was performed using disk diffusion and isolates were sent to a reference laboratory for agar dilution direct susceptibility testing. Five hundred and seventy-five patients were screened. There were 33 (5.7%) patients with gonorrhoea detected by PCR. Of the 16 viable N. gonorrhoeae isolates, 100% were resistant to ciprofloxacin and tetracycline by disk diffusion and 31% exhibited reduced susceptibility to ceftriaxone and cefixime. By agar dilution, 100% of isolates were resistant to ciprofloxacin and all isolates were susceptible to ceftriaxone and cefixime. There was concordance between disk diffusion and agar dilution for ciprofloxacin and tetracycline resistance and a significant discordance for third-generation cephalosporins. More than half the women with gonorrhoea were asymptomatic and represent a potential reservoir for ongoing transmission. AMR testing of N. gonorrhoeae isolates is needed to ensure optimal treatment and prevention of antibiotic resistance progression.

Get full access to this article

View all access and purchase options for this article.

References

1. WHO Media Centre. Antimicrobial resistance. Fact sheet, http://www.who.int/mediacentre/factsheets/fs194/en/ (2017, accessed 20 October 2017).
2. WHO Media Centre. Sexually transmitted infections (STIs). Fact sheet, http://www.who.int/mediacentre/factsheets/fs110/en/# (2016, accessed 2 January 2017).
3. World Health Organization. Antimicrobial resistance: global report on surveillance, http://apps.who.int/iris/bitstream/10665/112642/1/9789241564748_eng.pdf?ua=1 (2014, accessed 2 January 2017).
4. World Health Organization, Department of Reproductive Health and Research. Global action plan to control the spread and impact of antimicrobial resistance in Neisseria gonorrhoeae, http://www.who.int/reproductivehealth/publications/rtis/9789241503501/en/ (2012, accessed 10 September 2017).
5. World Health Organization. Global surveillance network for gonococcal antimicrobial susceptibility, http://apps.who.int/medicinedocs/documents/s16348e/s16348e.pdf (1990, accessed 10 September 2017).
6. Wi T, Lahra MM, Ndowa F, et al. Antimicrobial resistance in Neisseria gonorrhoeae: global surveillance and a call for international collaborative action. PLoS Med. Epub ahead of print July, 7 2017. 10.1371/journal.pmed.1002344.
7. Ndowa FJ, Francis JM, Machiha A, et al. Gonococcal antimicrobial resistance: perspectives from the African region. Sex Transm Infect 2013; 89: 11–15.
8. World Health Organization. WHO guidelines for the treatment of Neisseria gonorrhoeae, http://apps.who.int/iris/bitstream/10665/246114/1/9789241549691-eng.pdf (2016, accessed 7 December 2016).
9. Unemo M, Golparian D, Stary A, et al. First Neisseria gonorrhoeae strain with resistance to cefixime causing gonorrhoea treatment failure in Austria, 2011. Euro Surveill 2011; 16: 19998.
10. Fifer H, Natarajan U, Jones L, et al. Failure of dual antimicrobial therapy in treatment of gonorrhea. N Engl J Med 2016; 374: 2504–2506.
11. Ministry of Health. Uganda clinical guidelines 2012. http://apps.who.int/medicinedocs/documents/s21741en/s21741en.pdf (2012, accessed 2 January 2017).
12. Cockerill F, Wikler M, Alder et al. CLSI. Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Second Informational Supplement. CLSI document M100-S22. Wayne PA: Clinical and Laboratory Standards Institute; 2012; 32: 100–102.
13. Vandepitte J, Hughes P, Matovu G, et al. High prevalence of ciprofloxacin-resistant gonorrhea among female sex workers in Kampala, Uganda (2008–2009). Sex Transm Dis 2014; 41: 233–237.
14. Amito FP, Otim F, Okongo F, et al. The prevalence and antibiotics susceptibility pattern of Neisseria gonorrhoeae in patients attending OPD clinics at St. Mary’s Hospital Lacor Uganda. J Prev Med Hyg 2012; 53: 186–189.
15. Srifeung S, Roongpisuthipong A, Asavapiriyanont S, et al. Prevalence of Chlamydia trachomatis and Neisseria gonorrhoeae in HIV-seropositive patients and gonococcal antimicrobial susceptibility: an update in Thailand. Jpn J Infect Dis 2009; 62: 467–470.
16. Kiguba R, Karamagi C, Bird SM. Extensive antibiotic prescription rate among hospitalized patients in Uganda: but with frequent missed-dose days. J Antimicrob Chemother 2016; 71: 1697–1706.
17. Powell M, Future Science Group. Gonorrhoea – the current antibiotic pipeline and the need for new drugs, https://www.id-hub.com/2017/07/07/gonorrhoea-current-antibiotic-pipeline-need-new-drugs/ (2017, accessed 2 October 2017).
18. Liu H, Taylor TH Jr, Pettus K, et al. Assessment of Etest as an alternative to agar dilution for antimicrobial susceptibility of Neisseria gonorrhoeae. J Clin Microbiol 2014; 52: 1435–1440.
19. Liao CH, Lai CC, Hsu MS, et al. Antimicrobial susceptibility of Neisseria gonorrhoeae isolates determined by the agar dilution, disk diffusion and Etest methods: comparison of results using GC agar and chocolate agar. Int J Antimicrob Agents 2010; 35: 457–460.

Cite article

Cite article

Cite article

OR

Download to reference manager

If you have citation software installed, you can download article citation data to the citation manager of your choice

Share options

Share

Share this article

Share with email
EMAIL ARTICLE LINK
Share on social media

Share access to this article

Sharing links are not relevant where the article is open access and not available if you do not have a subscription.

For more information view the Sage Journals article sharing page.

Information, rights and permissions

Information

Published In

Article first published online: November 4, 2018
Issue published: March 2019

Keywords

  1. Gonorrhoea
  2. sexually transmitted infections
  3. antimicrobial resistance
  4. HIV

Rights and permissions

© The Author(s) 2018.
Request permissions for this article.
PubMed: 30392463

Authors

Affiliations

Emily Mabonga
Waldron Sexual Health Centre, Lewisham and Greenwich NHS Trust, London, UK
Rosalind Parkes-Ratanshi
Cambridge Institute of Public Health, University of Cambridge, Cambridge, UK
Infectious Disease Institute, Makerere University College of Health Sciences, Kampala, Uganda
Stefan Riedel
Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA
Sheila Nabweyambo
Infectious Disease Institute, Makerere University College of Health Sciences, Kampala, Uganda
Olive Mbabazi
Infectious Disease Institute, Makerere University College of Health Sciences, Kampala, Uganda
Chris Taylor
King’s College Hospital, London, UK
Charlotte Gaydos
Division of Infectious Diseases, Department of Medicine, Johns Hopkins University, Baltimore, MD, USA
Yukari C Manabe
Infectious Disease Institute, Makerere University College of Health Sciences, Kampala, Uganda
Division of Infectious Diseases, Department of Medicine, Johns Hopkins University, Baltimore, MD, USA

Notes

Emily Mabonga, Waldron Sexual Health Centre, Lewisham and Greenwich NHS Trust, London SE14 6LD, UK. Email: [email protected]

Metrics and citations

Metrics

Journals metrics

This article was published in International Journal of STD & AIDS.

VIEW ALL JOURNAL METRICS

Article usage*

Total views and downloads: 210

*Article usage tracking started in December 2016


Altmetric

See the impact this article is making through the number of times it’s been read, and the Altmetric Score.
Learn more about the Altmetric Scores



Articles citing this one

Receive email alerts when this article is cited

Web of Science: 9 view articles Opens in new tab

Crossref: 9

  1. Antimicrobial susceptibility surveillance and antimicrobial resistance...
    Go to citation Crossref Google Scholar
  2. The resistance mechanisms of bacteria against ciprofloxacin and new ap...
    Go to citation Crossref Google Scholar
  3. Antimicrobial Resistance of Neisseria gonorrhoeae in Sub-Saharan Popul...
    Go to citation Crossref Google Scholar
  4. Antibiotic-resistant Neisseria gonorrhoeae and changes to the 2019 Rwa...
    Go to citation Crossref Google ScholarPub Med
  5. Implementation of a standardised and quality-assured enhanced gonococc...
    Go to citation Crossref Google Scholar
  6. Point-by-Point Progress: Gonorrhea Point of Care Tests
    Go to citation Crossref Google Scholar
  7. Sharp increase in ciprofloxacin resistance of Neisseria gonorrhoeae in...
    Go to citation Crossref Google ScholarPub Med
  8. Antimicrobial resistance of Neisseria gonorrhoeae in Jakarta, Indonesi...
    Go to citation Crossref Google Scholar
  9. Antimicrobial Resistance of Neisseria Gonorrhoeae in a Newly Implement...
    Go to citation Crossref Google Scholar

Figures and tables

Figures & Media

Tables

View Options

Get access

Access options

If you have access to journal content via a personal subscription, university, library, employer or society, select from the options below:

BASHH and EADV members can access this journal content using society membership credentials.


BASHH and EADV members can access this journal content using society membership credentials.



Alternatively, view purchase options below:

Purchase 24 hour online access to view and download content.

Access journal content via a DeepDyve subscription or find out more about this option.

View options

PDF/ePub

View PDF/ePub

Full Text

View Full Text